EAElaine Cristina de Ataide

Elaine Cristina de Ataide

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elaine Cristina de Ataide has a total of 137 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevention of bronchopulmonary aspiration in digestive surgery: the impact of training healthcare professionals

    by Marcelo Gustavo Pereira, Guilherme Kenji Sacamoto Guimarães, Franciele Ferreira Belizario, Elaine Cristina Ataíde, Ivan Felizardo Contrera Toro, Ilka Fatima Santana Ferreira Boin

    Background: Bronchopulmonary aspiration occurs when food or fluids enter the lower airways, potentially causing hypoxia, aspiration pneumonia, and even death. Prevention requires early identification of risks and action by a multidisciplinary team. Continuous team education, using well established protocols, is essential to reinforce preventive measures and improve healthcare. Aims: Based on the well-established protocols, evaluate the impact of training on professional learning and the incidence of bronchopulmonary aspiration. Methods: A prospective, blinded, time-allocated, quasi-experimental study conducted in the gastrointestinal surgery ward and intensive care unit. The study was divided into three phases: patient assessment, multidisciplinary training based on the well-established protocols, and patient reassessment regarding risks, bronchopulmonary aspiration, and outcomes. Results: The study included 600 of the 710 patients evaluated, distributed in two phases: Phase 1 (n=267) and Phase 3 (n=333). Sixty-six professionals participated in Phase 2. The impact of training on bronchopulmonary aspiration was assessed through pre- and post-training assessments. The score increased significantly (pre-test: 75.06±13.36; post-test: 93.58±5.63; p<0.0001). In Phase 1, 32 patients presented with bronchopulmonary aspiration; in Phase 3, this number was 20, a significant difference (p=0.0097). Conclusions: Training proved effective in preventing bronchopulmonary aspiration and improving clinical outcomes, with a positive impact at all levels of the protocol employed. The results reinforce continuing education as a strategy for patient safety and risk management, suggesting its application in other healthcare settings.

  • Open Access

    Opportunistic computed tomography-based sarcopenia screening and mortality after liver transplantation: a systematic review and meta-analysis.

    by Daniel Alvarenga Fernandes, Daniel Bohn, Pedro Antune da Silva Pereira, Mila Mucci, Vittor Hugo Andrade Marques, Paula Juliano Lopes de Faria, Elaine Cristina de Ataide, João Rafael Terneira Vicentini, Nelson Marcio Gomes Caserta, Ilka de Fátima Santana Ferreira Boin

    The aim of this study was to investigate the diagnosis of sarcopenia in chronic liver disease by opportunistic computed tomography screening using the Psoas Muscle Index method as a predictor of mortality after liver transplantation. We systematically searched PubMed, Scopus, and Cochrane Central Register of Controlled Trials from July 2014 to July 2024. We restricted inclusion in this meta-analysis to observational studies and clinical trials on adult patients with chronic liver disease diagnosed with sarcopenia by computed tomography undergoing liver transplantation or on a waiting list. We included the one with a larger sample size for studies with overlapping populations. We excluded studies with therapeutic interventions, animal experiments, cell-line studies, editorial pieces, commentaries, review articles, and case reports. After the removal of duplicate records and ineligible studies, 163 remained and were thoroughly reviewed based on inclusion criteria. Of these, a total of 11 studies were included in qualitative synthesis and four studies were included in quantitative analysis (meta-analysis), comprising 382 patients. Patients with muscle mass loss after liver transplantation diagnosed by computed tomography scan using the Psoas Muscle Index method had a 4.1 times higher risk of death than non-sarcopenic patients (random-effects model: OR 4.1386; 95%CI 2.4215-7.0730; p<0.0001). Interpretatively, a scale with an I2 value close to 0% indicates no heterogeneity. The other criteria also did not reject the hypothesis of homogeneity among the articles. Patients with muscle mass loss diagnosed by computed tomography using the Psoas Muscle Index method had a fourfold increased mortality risk after transplantation. The findings reinforce the need to identify sarcopenic patients preoperatively to optimize liver transplantation outcomes. Using the Psoas Muscle Index, an opportunistic diagnosis by computed tomography scan can be helpful in this setting.


  • Open Access

    Bacterial and Fungal Infections in Postoperative Liver Transplantation and Their Relationship with the Donor

    by Felício Chueiri Neto, Ruan Tadeu Alves, Rafaela Hamada Jucá, Simone Reges Perales, Ilka de Fátima Santana Ferreira Boin, Elaine Cristina de Ataíde

    Introduction: Nosocomial infections remain a significant cause of adverse outcomes following liver transplantation. Donor-derived infections (DDIs) are rare but potentially life-threatening in this context. Bacterial and fungal infections are among the most common forms of DDI. Given the shortage of organs and the high number of patients on the waiting list, it is crucial to determine whether the use of organs from donors with positive cultures is harmful or feasible. Objectives: To evaluate the incidence and impact of general infections, of the use of positive-culture donors, and of DDIs on liver transplant outcomes. Methods: This retrospective observational study was conducted at the Hospital Geral, Universidade de Campinas. Digital records of all transplant recipients from April 2021 to January 2024 were reviewed to identify positive cultures, records of infection at the time of positive culture, and donor cultures. DDI was considered present when patients developed infection by the same agent isolated from the donor, provided they had not been colonized before. Kaplan-Meier curves were used to define survival, with Breslow’s test for comparison between groups with or without infection and with or without positive donor cultures. Results: Ninety liver transplants were performed in 86 patients. Among the 90 donors, nine (10%) had positive cultures, and four (4.4%) met the criteria for bloodstream infection. Among the recipients, 26 (30.2%) developed infections with positive cultures during the 60 days following liver transplantation. No infections in recipients were linked to donors. There was no difference in mortality between those who received livers from positive-culture donors and negative-culture donors. Additionally, no difference in mortality was observed between those who developed infections and those who did not. Intensive care unit length of stay was higher in recipients who developed infections. Conclusion: Infections remain an important cause of postoperative morbidity among liver transplant recipients, justifying concern about DDIs. However, positive-culture donors might be suitable for transplantation when no evident sepsis is present at the time of organ harvest. The design of this study is limited, and therefore, it is imperative to confirm these findings with further prospective studies.

  • Open Access

    Infecções Bacterianas e Fúngicas em Pós-Operatório de Transplante Hepático e Sua Relação com Doador

    by Felício Chueiri Neto, Ruan Tadeu Alves, Rafaela Hamada Jucá, Simone Reges Perales, Ilka de Fátima Santana Ferreira Boin, Elaine Cristina de Ataíde

    Introdução: Infecções nosocomiais continuam sendo uma causa significativa de desfechos adversos após o transplante de fígado. Infecções relacionadas ao doador são raras, mas potencialmente fatais nesse contexto. Infecções bacterianas e fúngicas estão entre as formas mais comuns de infecções relacionadas ao doador. Dada a escassez de órgãos e o elevado número de pacientes na lista de espera, é crucial determinar se o uso de órgãos de doadores com culturas positivas é prejudicial ou viável. Objetivos: Avaliar a incidência e o impacto das infecções em geral, do uso de doadores com culturas positivas e das infecções relacionadas ao doador nos desfechos do transplante hepático. Métodos: Este estudo observacional retrospectivo foi realizado no Hospital Geral da Universidade de Campinas. Foram revisados os prontuários digitais de todos os receptores de transplante hepático entre abril de 2021 e janeiro de 2024 para identificar culturas positivas, registros de infecção no momento da cultura positiva e culturas dos doadores. Considerou-se infecção relacionada ao doador presente quando os pacientes desenvolveram infecção pelo mesmo agente isolado do doador, desde que não estivessem previamente colonizados. Curvas de Kaplan-Meier foram utilizadas para definir a sobrevida, com o teste de Breslow para comparação entre os grupos com ou sem infecção e com ou sem culturas positivas dos doadores. Resultados: Foram realizados 90 transplantes de fígado em 86 pacientes. Entre os 90 doadores, nove (10%) apresentaram culturas positivas, e quatro (4,4%) atenderam aos critérios para infecção da corrente sanguínea. Entre os receptores, 26 (30,2%) desenvolveram infecções com culturas positivas nos 60 dias após o transplante hepático. Nenhuma infecção nos receptores foi relacionada aos doadores. Não houve diferença na mortalidade entre aqueles que receberam fígados de doadores com culturas positivas e aqueles com culturas negativas. Além disso, não foi observada diferença na mortalidade entre os que desenvolveram infecções e os que não desenvolveram. O tempo de permanência na unidade de terapia intensiva foi maior nos receptores que desenvolveram infecções. Conclusão: As infecções continuam sendo uma causa importante de morbidade pós-operatória entre receptores de transplante hepático, justificando a preocupação com as infecções relacionadas ao doador. No entanto, doadores com culturas positivas podem ser adequados para transplante quando não há sepse evidente no momento da captação do órgão. O desenho deste estudo é limitado, sendo necessário confirmar esses achados com estudos prospectivos adicionais.

  • Open Access

    Sobrevivência a Longo Prazo após Transplante Ortotópico de Fígado: Análise de 20 anos em um Centro de Transplante em Campinas, Brasil

    by Victor Kenzo Ivano, Rafaela Hamada Jucá, Arthur Nunes Martins Neto, Fernanda Kreve, Tiago Diniz, Alexandre Foratto, Derli Conceição Munhoz, Eduardo Riccetto, Caique Fernandes Alves, Simone Reges Perales, et al.

    Introdução: O transplante ortotópico de fígado (TOF) é a principal terapia para doença hepática terminal. No Brasil, a realização de transplantes aumentou significativamente nas últimas décadas, com melhorias nos desfechos a longo prazo. Este estudo analisa a sobrevida de pacientes submetidos a TOF ao longo de 20 anos em um centro de referência. Métodos: Foram revisados os prontuários de 848 pacientes transplantados entre fevereiro de 1995 e dezembro de 2017. Aplicaram-se critérios de exclusão, incluindo pacientes com sobrevida inferior a 6 meses, visando minimizar o impacto de complicações precoces no desfecho de longo prazo. Dessa forma, 174 pacientes foram incluídos. As variáveis analisadas envolveram dados do receptor, doador, enxerto, procedimento cirúrgico e evolução pós-operatória. A sobrevida foi avaliada por Kaplan–Meier. Resultados: Dos 174 pacientes analisados, 98 (56,3%) mantiveram seguimento ambulatorial e 76 (43,7%) evoluíram a óbito. A média de idade no transplante foi de 47 anos, e 75% dos receptores eram do sexo masculino. As principais indicações foram hepatite viral (59,8%) e carcinoma hepatocelular (11,6%). A média do escore MELD foi 18. A principal causa de morte foi evento cardiovascular (36,4%), seguido de recidiva da doença hepática (22,1%) e neoplasias (15,6%). O tempo médio de sobrevida foi de 223 meses entre os pacientes vivos e 112 meses entre os óbitos (p < 0,0001). Maior tempo de isquemia fria, insuficiência renal pós-operatória, diabetes e maior tempo de internação em UTI foram fatores associados a pior sobrevida. Pacientes mais jovens apresentaram sobrevida significativamente superior (p = 0,00007). Conclusão: A análise de 20 anos mostrou que o TOF apresenta boa sobrevida a longo prazo, mas fatores como diabetes, disfunção renal e tempo prolongado de isquemia fria impactam negativamente os desfechos. Eventos cardiovasculares e recidiva da doença hepática foram as principais causas de mortalidade.

  • Open Access

    Long-Term Survival after Orthotopic Liver Transplant: 20-year analysis at a Transplant Center in Campinas, Brazil

    by Victor Kenzo Ivano, Rafaela Hamada Jucá, Arthur Nunes Martins Neto, Fernanda Kreve, Tiago Diniz, Alexandre Foratto, Derli Conceição Munhoz, Eduardo Riccetto, Caique Fernandes Alves, Simone Reges Perales, et al.

    Introduction: Orthotopic liver transplantation (OLT) is the primary therapy for end-stage liver disease. In Brazil, the number of liver transplants has significantly increased over the past decades, improving long-term outcomes. This study analyzes the long-term survival of patients who underwent OLT over 20 years at a reference transplant center. Methods: Medical records of 848 patients who underwent OLT between February 1995 and December 2017 were reviewed. Exclusion criteria included patients with survival below six months to minimize the impact of early postoperative complications on long-term outcomes. Thus, 174 patients were included. The analyzed variables involved the recipient, donor, graft, surgical procedure, and postoperative evolution. Survival was assessed using Kaplan–Meier analysis. Results: Among the 174 analyzed patients, 98 (56.3%) remained in outpatient follow-up, while 76 (43.7%) died. The mean age at transplantation was 47 years, and 75% of recipients were male. The main indications were viral hepatitis (59.8%) and hepatocellular carcinoma (11.6%). The mean MELD score was 18. The leading cause of death was cardiovascular events (36.4%), followed by liver disease recurrence (22.1%) and malignancies (15.6%). The mean survival time was 223 months for surviving patients and 112 months for deceased patients (p < 0.0001). Longer cold ischemia time, postoperative renal dysfunction, diabetes, and prolonged stay in the intensive care unit were associated with worse survival. Younger patients had significantly longer survival (p = 0.00007). Conclusion: The 20-year analysis demonstrated that OLT provides good long-term survival; however, factors such as diabetes, renal dysfunction, and prolonged cold ischemia time negatively impact the outcomes. Cardiovascular events and recurrence of liver disease were the leading causes of mortality.

  • Silent Destruction: Fulminant Hepatitis and the Hidden Danger of Weight Loss Drugs

    by Elaine Cristina de Ataide, Simone Reges Perales, Ana Paula Nunes Bento, Fernanda Dias Teramoto, Marcella Tardelli Falleiros Lima, Marlone Cunha-Silva, Carla Batista Moisés, Letícia Fernandes Kawamoto Do Nascimento, Vanessa Aguiar, Tiago Sevá-Pereira, et al.

  • Liver Transplantation After Previous Vena Cava Resection: Case Report

    by Elaine Cristina de Ataide, Simone Reges Perales, Fernanda Dias Teramoto, Alexandre Foratto, Cristhian Jaillita Meneses, Daniela Ciancio Marcondes, Marcella Tardelli Falleiros Lima, Letícia Fernandes Kawamoto Do Nascimento, Vanessa Aguiar, Marlone Cunha-Silva, et al.

  • Open Access

    Giant hepatic hemangioma in a patient with cirrhosis: challenging to manage

    by Marlone Cunha-Silva, Clauber Teles Veiga, Larissa Bastos Eloy da Costa, Simone Reges Perales, Amanda Avesani Cavotto Furlan, Elaine Cristina de Ataíde, Ilka de Fátima Santana Ferreira Boin, Tiago Sevá-Pereira

    Autops Case Rep, vol.14, e2024485, 2024


  • Open Access

    Cortical ribbon sign on neuroimaging in a patient with hepatic encephalopathy secondary to herbal medicine usage

    by Gabriel de Deus Vieira, Mariana Moreira Soares de Sá, Arthur de Medeiros Dias, Rafael Gemaque Lima Bentes, Augusto Celso Scarparo Amato, André Augusto Lemos Vidal de Negreiros, Ana Carolina Amaral de Andrade, Simone Reges Perales, Elaine Cristina de Ataide, Alexandre Foratto, et al.

    The use of herbal medicines is growing exponentially despite the lack of scientific evidence regarding their effectivity and toxicity. ( , ) Moreover, the use of herbal medicines have been reported to be common in patients with chronic liver disease (30–62%); these medicines can lead to hepatotoxicity and serious hepatic side effects. ( ) Hepatic encephalopathy is a complication of acute liver failure and chronic liver disease that causes cognitive dysfunction, motor deficits, and seizures. ( , ) Gastrointestinal hemorrhage,